Immunohistochemistry (IHC) - Market Insights, Competitive Landscape and Market Forecast–2026
No. of Pages: 120
Researcher’s ‘Immunohistochemistry (IHC) - Market Insights, Competitive Landscape and Market Forecast–2026’ report delivers an in-depth understanding of Immunohistochemistry (IHC) and the historical and forecasted Immunohistochemistry
|
13-Apr-2021
|
4750
|
Radiologic Cancer Therapy - Market Insights, Competitive Landscape and Market Forecast–2026
No. of Pages: 120
Researcher’s ‘Radiologic Cancer Therapy - Market Insights, Competitive Landscape and Market Forecast–2026’ report delivers an in-depth understanding of Radiologic Cancer Therapy and the historical and
|
13-Apr-2021
|
4750
|
Dialysis Devices - Market Insights, Competitive Landscape and Market Forecast–2026
No. of Pages: 120
Researcher’s ‘Dialysis Devices - Market Insights, Competitive Landscape and Market Forecast–2026’ report delivers an in-depth understanding of Dialysis Devices and the historical and forecasted Dialysis
|
13-Apr-2021
|
4750
|
Medical Vacuum Regulator - Market Insights, Competitive Landscape and Market Forecast–2026
No. of Pages: 120
Researcher’s ‘Medical Vacuum Regulator - Market Insights, Competitive Landscape and Market Forecast–2026’ report delivers an in-depth understanding of Medical Vacuum Regulator and the historical and
|
13-Apr-2021
|
4750
|
P selectin inhibitors - Pipeline Insight, 2021
No. of Pages: 60
Researcher’s, “P selectin inhibitors - Pipeline Insight, 2021,” report provides comprehensive insights about 8+ companies and 8+ pipeline drugs in P selectin inhibitors pipeline landscape.
|
30-Mar-2021
|
1500
|
Interleukin-33 inhibitors - Pipeline Insight, 2021
No. of Pages: 60
Researcher’s, “Interleukin-33 inhibitors - Pipeline Insight, 2021,” report provides comprehensive insights about 7+ companies and 7+ pipeline drugs in Interleukin-33 inhibitors pipeline landscape. It covers
|
30-Mar-2021
|
1500
|
Antisense Oligonucleotide Therapeutics - Pipeline Insight, 2021
No. of Pages: 60
Researcher’s, “Antisense Oligonucleotide Therapeutics - Pipeline Insight, 2021,” report provides comprehensive insights about 15+ companies and 15+ pipeline drugs in Antisense Oligonucleotide Therapeutics pipeline landscape.
|
30-Mar-2021
|
1500
|
Glucagon-Like Peptide 1 Receptor Agonists - Pipeline Insight, 2021
No. of Pages: 100
Researcher’s, “Glucagon-Like Peptide 1 Receptor Agonists - Pipeline Insight, 2021,” report provides comprehensive insights about 30+ companies and 30+ pipeline drugs in Glucagon-Like Peptide 1
|
30-Mar-2021
|
2000
|
Glucosylceramide synthase inhibitors - Pipeline Insight, 2021
No. of Pages: 60
Researcher’s, “Glucosylceramide synthase inhibitors - Pipeline Insight, 2021,” report provides comprehensive insights about 5+ companies and 5+ pipeline drugs in Glucosylceramide synthase inhibitors pipeline landscape.
|
30-Mar-2021
|
1500
|
GABA A receptor agonist - Pipeline Insight, 2021
No. of Pages: 60
Researcher’s, “GABA A receptor agonist - Pipeline Insight, 2021,” report provides comprehensive insights about 10+ companies and 10+ pipeline drugs in GABA A receptor agonist
|
30-Mar-2021
|
1500
|
Plasminogen activators - Pipeline Insight, 2021
No. of Pages: 60
Researcher’s, “Plasminogen activators - Pipeline Insight, 2021,” report provides comprehensive insights about 10+ companies and 10+ pipeline drugs in Plasminogen activators pipeline landscape. It covers
|
30-Mar-2021
|
1500
|
Serotonin receptor 2 angonist - Pipeline Insight, 2021
No. of Pages: 60
Researcher’s, “Serotonin receptor 2 Agonist– Pipeline Insight, 2021,” report provides comprehensive insights about 5+ companies and 5+ pipeline drugs in Serotonin receptor 2 Agonist pipeline
|
30-Mar-2021
|
1500
|
Platelet-derived growth factor receptor antagonists - Pipeline Insight, 2021
No. of Pages: 60
Researcher’s, “Platelet-derived growth factor receptor antagonists - Pipeline Insight, 2021,” report provides comprehensive insights about 15+ companies and 15+ pipeline drugs in Platelet-derived growth factor
|
30-Mar-2021
|
1500
|
TIL therapy - Pipeline Insight, 2021
No. of Pages: 120
Researcher’s, “TIL Therapy – Pipeline Insight, 2021,” report provides comprehensive insights about 30+ companies and 30+ pipeline drugs in TIL Therapy pipeline landscape. It covers
|
30-Mar-2021
|
2000
|
Dopamine D2 receptor antagonist - Pipeline Insight, 2021
No. of Pages: 60
Researcher’s, “Dopamine D2 receptor antagonists– Pipeline Insight, 2021,” report provides comprehensive insights about 10+ companies and 10+ pipeline drugs in Dopamine D2 receptor antagonists pipeline
|
30-Mar-2021
|
1500
|
Enhancer of zeste homolog 2 protein inhibitors - Pipeline Insight, 2021
No. of Pages: 60
Researcher’s, “Enhancer of zeste homolog 2 protein inhibitors– Pipeline Insight, 2021,” report provides comprehensive insights about 10+ companies and 10+ pipeline drugs in Enhancer of
|
30-Mar-2021
|
1500
|
Potassium channel antagonists - Pipeline Insight, 2021
No. of Pages: 60
Researcher’s, “Potassium channel antagonists– Pipeline Insight, 2021,” report provides comprehensive insights about 10+ companies and 10+ pipeline drugs in Potassium channel antagonists pipeline landscape. It
|
30-Mar-2021
|
1500
|
Basal cell carcinoma - Pipeline Insight, 2021
No. of Pages: 80
Researcher’s, “Basal cell carcinoma - Pipeline Insight, 2021,” report provides comprehensive insights about 25+ companies and 25+ pipeline drugs in Basal cell carcinoma pipeline landscape.
|
15-Mar-2021
|
2000
|
Chondrosarcoma - Pipeline Insight, 2021
No. of Pages: 60
Researcher’s, “Chondrosarcoma - Pipeline Insight, 2021,” report provides comprehensive insights about 6+ companies and 6+ pipeline drugs in Chondrosarcoma pipeline landscape. It covers the pipeline
|
15-Mar-2021
|
1500
|
Ewing’s Sarcoma - Pipeline Insight, 2021
No. of Pages: 60
Researcher’s, “Ewing’s Sarcoma – Pipeline Insight, 2021,” report provides comprehensive insights about 10+ companies and 10+ pipeline drugs in Ewing’s Sarcoma pipeline landscape. It covers
|
15-Mar-2021
|
1500
|
